SPAN-AMERICA SELLS CONTRACT PACKAGING BUSINESS
Company to Focus on Core Medical Business
Greenville, South Carolina (March 2, 1998) -- Span-America Medical Systems, Inc.
(Nasdaq/NM:SPAN) announced today that it sold substantially all of the assets of its contract
packaging business unit on February 27, 1998.
"We believe the sale of the contract packaging unit will allow Span-America's management to
focus on the growth of our core medical business," stated Jim Ferguson, president and chief
executive officer of Span-America Medical Systems, Inc. "The sale will also free up space in our
main plant in the near future, allowing us to consolidate our off-site consumer manufacturing into
our Greenville plant to reduce manufacturing costs and improve overall operating efficiencies."
The purchase price for the contract packaging assets is $2.3 million, with $1.84 million paid in
cash at closing and the remainder financed by Span-America over five years. The Company
anticipates that no material gain or loss will be recorded in the current quarter as a result of the
sale. The contract packaging business accounted for approximately 19% of Span-America's
revenues and 8% of total operating profit in fiscal 1997.
The buyer of the contract packaging unit is Span Contract Packaging, Inc., a new company
formed by long-time Span-America contract packaging managers, Ian Simpson and Les Teague.
The new business is expected to operate at Span-America's Greenville plant for about six months
until the operations can be relocated to a larger building near its current location.
"We expect the sale of Span-America's contract packaging business to be mostly transparent to
our customers and employees," continued Mr. Ferguson. "Our customers and employees were a
prime concern in structuring this transaction. We plan to work closely with the new owners to
make the transition as smooth as possible."
Following the move of contract packaging, Span-America will close its consumer manufacturing
plant in nearby Greer, South Carolina, and relocate the employees and manufacturing operation
into the 50,000-square-foot plant vacated by contract packaging. The Company anticipates the
improved efficiencies of combining operations in Greenville and the effect of the recently
announced stock repurchase will minimize, and possibly offset, the lost profit contribution from
the sale of the contract packaging business.
"We believe the sale of the contract packaging business will allow our management to focus on
building our core medical business as we evolve into a clinically driven wound management
company. The wound management market encompasses our existing surface, seating, and
positioning products and includes new product opportunities in skin care, wound care, and
nutrition. In addition, we intend to leverage our manufacturing competencies developed in our
medical business to make and sell custom foam and related products in the consumer and
industrial markets," concluded Mr. Ferguson.
Span-America Medical Systems, Inc. manufactures and markets products to the health care
industry for the prevention and treatment of pressure ulcers. The Company also is a manufacturer
and marketer of custom foam and packaging products for the consumer and industrial markets.
Span-America's stock is traded on The Nasdaq Stock Market's National Market under the symbol
SPAN.
With the exception of historical factual information, the statements made in this press release
constitute forward-looking statements, contain the words "believes," "anticipates," "expects," and
words of similar import based upon current expectations and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. Management wishes
to caution the reader that these forward-looking statements such as management's expectations
for efficiency improvements and entering new markets are forecasts. Actual events or results
may differ materially as a result of risks facing the Company. Such risks include but are not
limited to: the timing of the proposed plant consolidation, the operating performance of Span
Contract Packaging, the loss of a major customer for the Company's consumer products, the
impact of competitive products and pricing in the wound management market, raw material costs
increases, and other risks referenced in the Company's Annual Report on Form 10-K. The
Company disclaims any obligation to update any forward-looking statements as a result of
developments occurring after the issuance of this press release.
[BACK TO NEWS RELEASE INDEX]